Inventi Impact - Psychiatry & Neurology
(Formerly Inventi Rapid/Impact: Brain)


  • Inventi:hbr/92/14
    Mohamed Murtuza Kauser, Kasi Jagadeesh M, Gopal Das C M, Santosh S V

    Metoclopramide is the prokinetic antiemetic drug which acts by blocking central dopaminergic receptors and is known to cause extra pyramidal symptoms (EPS) especially dystonia. They occur in 1% of patients given metoclopramide as anti-emetic in the medical ward. This neurological case study was about a young male patient who received only one dose of IV metoclopramide and developed acute dystonia. Symptoms disappeared after one dose of 50 mg I.V promethazine was given. A neurological rating scale called as extra pyramidal symptoms rating scale (ESRS) was used to assess EPS. Acute dystonia poses a serious challenge in the medical ward due to more chances of misdiagnosis such as seizures or psychogenic disorder (hysteria), stroke, tetanus, meningitis etc.

    How to Cite this Article
    Cite this article as: Mohamed Murtuza Kauser, Kasi Jagadeesh M, Gopal Das C M et al. Metoclopramide Induced Extrapyramidal Symptoms (Dystonia) in Adult Male Patient. Inventi Impact: Brain, 2014(4):157-159, 2014.
    Download Full Text